Antimicrobiology in Epidemiology

Antimicrobial resistance has become a serious healthcare problem, with high resistance rates of most common bacteria to clinically important antimicrobial agents. Resistance has emerged to even the newer, almost potent antimicrobial agents. Methicillin-resistant S. aureus, ESBL-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii represent more than 50% of microbial isolates. Furthermore, bacterial resistance to fluoroquinolones, macrolides and third-generation cephalosporins is of serious concern. The molecular epidemiology and resistance mechanisms of the antimicrobial strains exhibited regional specificity, as well as the influence of dissemination of international clonal complexes.


    Related Conference of Antimicrobiology in Epidemiology

    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 04-05, 2023

    35th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan
    February 08-09, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain

    Antimicrobiology in Epidemiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in